Publications
Filters: First Letter Of Title is R [Clear All Filters]
“A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa”, Antimicrob Agents Chemother, vol. 64, no. 3, 2020.
, “A randomised controlled trial of 3 versus 5 days artemether-lumefantrine regimen for uncomplicated Plasmodium falciparum treatment in pregnancy in Africa”, Antimicrob Agents Chemother, 2019.
, “Resolving the cause of recurrent Plasmodium vivax malaria probabilistically”, Nat Commun, vol. 10, no. 1, p. 5595, 2019.
, “Retrospective Review of Documentation Practices of Hepatitis B Immunoglobulin, Birth Dose, and Vaccination at the Hospital of Birth, in Thai Nationals and Migrants in Northern Thailand”, Open Forum Infect Dis, vol. 6, no. 12. p. ofz518, 2019.
, “Robust continuous in vitro culture of the Plasmodium cynomolgi erythrocytic stages”, Nat Commun, vol. 10, no. 1, p. 3635, 2019.
, , “Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study”, Malar J, vol. 17, no. 1, p. 427, 2018.
, “Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation?”, Expert Opin Drug Saf, vol. 15, no. 3, pp. 367-82, 2016.
, “Rheopathologic Consequence of Plasmodium vivax Rosette Formation”, PLoS Negl Trop Dis, vol. 10, no. 8, p. e0004912, 2016.
, “The role of early detection and treatment in malaria elimination”, Malar J, vol. 15, p. 363, 2016.
, “Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso”, Antimicrobial Agents and Chemotherapy, vol. 59, no. 8, pp. 4387-4396, 2015.
, “A randomized comparison of the efficacy and tolerability of three artemisinin-based combination treatments for children with acute falciparum malaria in The Democratic Republic of Congo”, Antimicrob Agents Chemother, 2014.
, “Rapid clinical assessment to facilitate the triage of adults with falciparum malaria, a retrospective analysis”, PLoS ONE, vol. 9, no. 1, p. e87020, 2014.
, “Reagent and laboratory contamination can critically impact sequence-based microbiome analyses”, BMC Biol, vol. 12, no. 1, p. 87, 2014.
, “Rectal pH in Well and Unwell Infants”, J Trop Pediatr, vol. 59, no. 2, p. 162, 2013.
, “Respiratory virus surveillance in hospitalised pneumonia patients on the Thailand-Myanmar border”, BMC Infectious Diseases, vol. 13, no. 1, p. 434, 2013.
, , “A randomised, double-blind, placebo controlled trial of monthly versus second monthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria”, Antimicrob Agents Chemother, vol. 56, no. 3, pp. 1571-1577, 2012.
, “Refugee and migrant women's views of antenatal ultrasound on the Thai Burmese border: a mixed methods study”, PLoS ONE, vol. 7, no. 4, p. e34018, 2012.
, “Risky alcohol use among reproductive-age men, not women, in Mae La refugee camp, Thailand, 2009”, Conflict and Health, vol. 6, no. 1, p. 7, 2012.
, “A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development”, Sci. Rep., vol. 1, 2011.
, “A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax”, Blood, vol. 118, no. 13, pp. 3454-3455, 2011.
, “A research agenda for malaria eradication: drugs”, PLoS Med, vol. 8, no. 1, p. e1000402, 2011.
, “A randomised, double-blind placebo controlled trial of two different dosing regimens of dihydroartemisinin-piperaquine for intermittent preventive treatment of adults at high risk of malaria in Thailand”, in 59th Meeting of the American Society of Tropical Medicine and Hygiene, Washington DC, USA, 2010, vol. 83, p. 372.
, “The reality of using primaquine”, Malar J, vol. 9, no. 1, p. 376, 2010.
, “Reproductive health and quality of life of young Burmese refugees in Thailand”, Confl Health, vol. 4, p. 5, 2010.
, “A Randomised Controlled Trial of Artemether-Lumefantrine Versus Artesunate for Uncomplicated Plasmodium falciparum Treatment in Pregnancy”, PLoS Medicine, vol. 5, no. 12, p. e253, 2008.
, “The relationship between age and the manifestations of and mortality associated with severe malaria”, Clin Infect Dis, vol. 47, no. 2, pp. 151-7, 2008.
, “The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria”, Malar J, vol. 7, no. 1, p. 149, 2008.
, “A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia”, Trop Med Int Health, vol. 12, no. 2, pp. 251-9, 2007.
, “Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites”, MOL BIOL EVOL, vol. 24, no. 2, pp. 562-73, 2007.
, “Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites”, J Infect Dis, vol. 195, no. 7, pp. 927-33, 2007.
, “Re: Malaria in pregnancy”, BJOG, vol. 113, no. 2, p. 246, 2006.
, “A Randomized Comparison of Artesunate-Atovaquone-Proguanil versus Quinine in Treatment for Uncomplicated Falciparum Malaria during Pregnancy”, J Infect Dis, vol. 192, no. 5, pp. 846-853, 2005.
, “A Randomized, Controlled Study of a Simple, Once-Daily Regimen of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated, Multidrug-Resistant Falciparum Malaria”, Clinical Infectious Diseases, vol. 41, no. 4, pp. 425-432, 2005.
, “A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand”, Malar J, vol. 4, no. 1, p. 46, 2005.
, “Relation of DDT residues to plasma retinol, a-tocopherol, and ฿-carotene during pregnancy and malaria infection: A case–control study in Karen women in northern Thailand”, Science of The Total Environment, vol. 363, no. 1-3, pp. 78-86, 2005.
, “Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic”, Clin Infect Dis, vol. 39, no. 8, pp. 1139-47, 2004.
, “Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand”, Journal of Infectious Diseases, vol. 190, no. 10, pp. 1773-82, 2004.
, “A randomized comparison of oral chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in Laos”, Trans R Soc Trop Med Hyg, vol. 97, no. 3, pp. 343-4, 2003.
, “Rapid genotyping of loci involved in antifolate drug resistance in Plasmodium falciparum by primer extension”, International Journal of Parasitology, vol. 32, no. 7, pp. 852-8., 2002.
, “Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 95, no. 6, pp. 651-6., 2001.
, “Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 6, pp. 689-93., 2000.
, “Risk factors for gametocyte carriage in uncomplicated falciparum malaria”, American Journal of Tropical Medicine and Hygiene, vol. 60, no. 6, pp. 1019-23, 1999.
, “Randomized comparison of artemether-benflumetol and artesunate- mefloquine in treatment of multidrug-resistant falciparum malaria”, Antimicrob Agents Chemother, vol. 42, no. 1, pp. 135-9, 1998.
, “The relationship between capillary and venous concentrations of the antimalarial drug lumefantrine (benflumetol)”, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 5, pp. 564-5, 1998.
, “Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand.”, Lancet, vol. 348, pp. 701-7, 1996.
,